African Union member states accelerates online pre-orders as AMSP adds 300 million Sputnik V doses to its COVID-19 vaccine portfolio

Joint Press Release

Johannesburg, February 19, 2021 — The Africa Vaccine Acquisition TaskTeam [AVATT], set up by the African Union to acquire additional vaccine doses so that Africa can attain a target immunization of 60%, is pleased to advise that it has received an offer of 300 million Sputnik V vaccines from the Russian Federation. This includes a financing package for any member states wishing to secure this vaccine.

Meanwhile, AVATT advises that the 270 million doses previously secured from AstraZeneca, Pfizer and Johnson & Johnsons were all taken up by the first allocation phase deadline through the African Medical Supplies Platform (AMSP). With these additional 300 million Sputnik V vaccines, AMSP accelerates online COVID-19 vaccines pre-orders for the 55 African Union member states.

“The Sputnik V vaccine from the Russian Federation is now available on the AMSP for the consideration of our AU Member States,” says Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC). “Bilateral and private sector partnerships such as these aid our efforts to bringing the COVID-19 pandemic to an end.”

While details, including clinical and technical information, are now accessible on the Africa Medical Supplies Platform (AMSP), Sputnik V vaccines will be available for a period of 12 months commencing by May 2021. From today, the 55 African Union member states are all invited to visit www.amsp.africa and use their national access code – issued to all African Union member states’ Ministers of Finance and Health – to start the pre-order process.

African Union member states that wish to secure funding should approach the African Export-Import Bank (Afreximbank) through their Central Banks, as has been the case with the other vaccines that have been on offer. The Board of Afreximbank, last week, approved the USD$ 2 billion Advance Purchase Commitment for the participating suppliers, allowing the finalization of supply contracts.

####

About Afreximbank

The African Export-Import Bank (Afreximbank) is a Pan-African multilateral financial institution with the mandate of financing and promoting intra-and extra-African trade. Afreximbank was established in October 1993 and owned by African governments, the African Development Bank and other African multilateral financial institutions as well as African and non-African public and private investors. The Bank was established under two constitutive documents, an Agreement signed by member states, which confers on the Bank the status of an international organization, and a Charter signed by all Shareholders, which governs its corporate structure and operations. Afreximbank deploys innovative structures to deliver financing solutions that are supporting the transformation of the structure of Africa’s trade, accelerating industrialization and intra-regional trade, thereby sustaining economic expansion in Africa. At the end of 2019, the Bank’s total assets and guarantees stood at USD$15.5 billion and its shareholders funds amounted to US$2.8 billion. Voted “African Bank of the Year” in 2019, the Bank disbursed more than US$38 billion between 2016 and 2020. Afreximbank has ratings assigned by GCR (international scale) (A-), Moody’s (Baa1) and Fitch (BBB-). The Bank is headquartered in Cairo, Egypt.

For more information, visit: www.afreximbank.com.

About Africa CDC

Africa Centres for Disease Control and Prevention (Africa CDC), is a specialized technical institution of the African Union that strengthens the capacity and capability of Africa’s public health institutions as well as partnerships to detect and respond quickly and effectively to disease threats and outbreaks, based on data-driven interventions and programmes.

Learn more at: www.africacdc.org

Africa Centres for Disease Control and Prevention (Africa CDC), is a specialized technical institution of the African Union that strengthens the

About AVATT

The African Vaccine Acquisition Task Team (AVATT), was established by African Union Chair, President Cyril Ramaphosa, as a component in support of the Africa Vaccine Strategy that was endorsed by the AU Bureau of Heads of State and Government on 20th of August 2020. The AVATT is chaired by President Ramaphosa and includes African Union Commission Chairperson Moussa Faki Mahamat, Dr. Zweli Lawrence Mkhize, Mr. Strive Masiyiwa, Dr. Donald Kaberuka, Professor Benedict Oramah, H.E. Amira Elfadil, Dr. John Nkengasong and others, as to be nominated by the Chair of the African Union and the Chairperson of the Commission.

About AMSP

The Africa Medical Supplies Platform (AMSP) is a non-profit initiative launched by the African Union as an immediate, integrated and practical response to the Covid-19 pandemic. The online platform was developed under the leadership of the African Union Special Envoy, Strive Masiyiwa and powered by Janngo on behalf of the African Union’s Africa Centres for Disease Control and Prevention (Africa CDC) and in partnership with African Export-Import Bank (Afreximbank) and United Nations Economic Commission for Africa (ECA) with the support of leading African & international Institutions, Foundations & Corporations as well as Governments of China, Canada & France.

For more information visit www.amsp.africa

About Janngo

Janngo builds, grows and invests in pan-African digital champions with proven business models and inclusive social impact. It builds digital ecosystems in high growth sectors by providing business support and digital platforms allowing Small and Medium Enterprises (SMEs) to scale and contribute to the economic empowerment of youth and women through job creation and capacity building.

For more information visit www.janngo.africa

Media Contacts

Janngo & AMSP
Antonia Gleizes
+336-23-13-71-72
media@janngo.africa

AVATT
George Sibotshiwe
+27-71-467-7689
george@nubiconafrica.co.za

Africa CDC
James Ayodele
+252-953-912-454
ayodelej@africa-union.org

Afreximbank
Amadou Labba Sall
+20-120-532-0254
asall@afreximbank.com